Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Sleep problems: Poor quality or insufficient sleep
Retatrutide (LY3437943) is an investigational triple hormone receptor agonist that activates: GLP-1 (glucagon-like peptide-1) receptor GIP (glucose-dependent insulinotropic polypeptide) receptor Glucagon (GCG) receptor This triple G mechanism targets multiple pathways for appetite control, insulin sensitivity, glucose regulation, and energy/fat metabolismpotentially offering greater effects than dual (GLP-1/GIP) or single agonists
The overall incidence of nausea was 27% in the retatrutide group
Wegovy Pill vs GLP-1 Injections: Clinical Trial Comparison Below, we've laid out the most commonly used clinical trial data for the GLP-1 treatments mentioned above
Developing tailored nutrition and lifestyle plans to support optimal weight health
US$ 28.95
US$ 21.74
US$ 23.57
US$ 27.88
US$ 25.39
